HANetf ICAV Indxx Healthcare Innovation UCITS ETF Acc (WELP)
2.15p
(0.40%)
- Add to watchlist
- Create an alert
- This stock can be held in a
2.15p
(0.40%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
2.15p
(0.40%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
533.90p
538.33p
666.70p
London
532.50p
533.30p
481.50p
$10.78M
0.90p (0.17%) Previous:
0.90p
364
n/a
GBX
ETP Basics
| Issuer: | HANetf ICAV |
|---|---|
| Structure: | ETF |
| Replication method: | Stocks - Optimised |
| Securities lending: | No |
| Number of holdings: | 102 |
| Size: | $10.8M |
| Launch date: | 04 April 2019 |
| Launch price: | $7.77 |
| UCITS: | Yes |
| Reporting status: | Yes |
| Domicile: | Ireland |
| Complex product: | Non-complex |
| ISIN: | IE00BJQTJ848 |
Annual & interim reports
Before you invest, please make sure you read the documents below
Ready to invest?
Important Documents
There are no documents available for this stock.
OBJECTIVE
| Index: | The Indxx Global NextGen Healthcare Index is designed to measure the performance of companies involved in the NextGen Healthcare sector, as defined by Indxx. |
|---|---|
| Aim: |
The Fund seeks to track the price and yield performance, before fees and expenses, of...
Read full aim for HANetf ICAV |
| Leverage: | 100% |
| Currency hedging: | No |
COSTS
| Ongoing Charge (OCF/TER): | 0.59% |
|---|---|
| Management fee: | 0.59% |
| Indicative spread: | 0.28% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
Not available for this stock.
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
| Security | Weight |
|---|---|
| PROTHENA CORP | 2.01% |
| ALIBABA HEALTH INFORMATION TECH LTD | 1.68% |
| 1LIFE HEALTHCARE INC | 1.65% |
| SOSEI GROUP CORP | 1.61% |
| SAREPTA THERAPEUTICS | 1.52% |
| PENUMBRA INC | 1.52% |
| ALNYLAM PHARMACEUTICALS | 1.45% |
| TELIX PHARMACEUTICALS LTD | 1.42% |
| DEXCOM | 1.40% |
| ABIOMED INC | 1.38% |
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.